Roche Decides Not to Extend Its Tender Offer for Illumina on Apparent Re-Election of Incumbent Directors; Says Offer Above $51 Not in Shareholder Interest

Roche RHHBY released the following statement based on preliminary estimates indicating the re-election of the incumbent directors of Illumina, Inc. ILMN at the Illumina annual meeting: In view of the apparent re-election of the incumbent directors of Illumina, Roche has decided not to extend its $51.00 cash tender offer for all of the shares of Illumina. The offer will expire at 6:00 p.m., New Yo
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDAM&A
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!